Preventive effects of kilohertz frequency electrical stimulation on sepsis-induced muscle atrophy

M Tanaka1, K Tanaka, J Tategaki

  • 1Department of Rehabilitation Science, Kobe University Graduate School of Health Sciences, 7-10-2 Tomogaoka, Suma-ku, Kobe 654-0142, Japan.

Abstract

Insights

Kilohertz electrical stimulation (ES) mitigated sepsis-induced muscle atrophy in mice. ES treatment reduced muscle mass loss and key protein markers associated with muscle wasting, suggesting a protective role.

Area of Science:

  • Biomedical Engineering
  • Physiology
  • Molecular Biology

Background:

  • Sepsis is a life-threatening condition characterized by a dysregulated host response to infection.
  • Sepsis frequently leads to muscle atrophy, contributing to prolonged recovery and increased morbidity.
  • The ubiquitin-proteasome pathway plays a critical role in the catabolism of muscle proteins during sepsis.

Purpose of the Study:

  • To investigate the efficacy of kilohertz frequency electrical stimulation (ES) in preventing muscle atrophy induced by sepsis.
  • To evaluate the impact of ES on muscle mass, fiber cross-sectional area, and specific molecular markers of muscle degradation.

Main Methods:

  • Sepsis was induced in male ICR mice using lipopolysaccharide (LPS) injection over four days.
  • Mice were divided into control, LPS-induced sepsis, and LPS with ES treatment groups.
  • Muscle atrophy was assessed by measuring tibialis anterior muscle weight, fiber cross-sectional area (CSA), and analyzing inflammatory cytokines and ubiquitinated proteins via ELISA and Western blot.

Main Results:

  • LPS injection significantly increased inflammatory cytokines and induced muscle mass loss (-29.0%) and decreased fiber CSA.
  • Electrical stimulation (ES) attenuated sepsis-induced muscle mass loss (-23.1%) and preserved fiber CSA.
  • ES treatment also reduced the upregulation of atrogin-1 and ubiquitinated proteins in the tibialis anterior muscle.

Conclusions:

  • Kilohertz frequency electrical stimulation demonstrates a protective effect against sepsis-induced muscle atrophy.
  • ES may exert its beneficial effects by inhibiting the ubiquitin-proteasome pathway, a key mechanism in muscle protein degradation.
  • These findings suggest ES as a potential therapeutic strategy to combat muscle wasting in sepsis patients.